Cargando…
Eribulin alone or in combination with the PLK1 inhibitor BI 6727 triggers intrinsic apoptosis in Ewing sarcoma cell lines
In this study, we investigated the molecular mechanisms of eribulin-induced cell death and its therapeutic potential in combination with the PLK1 inhibitor BI 6727 in Ewing sarcoma (ES). Here, we show that eribulin triggers cell death in a dose-dependent manner in a panel of ES cell lines. In additi...
Autores principales: | WeiΔ, Lilly Magdalena, Hugle, Manuela, Fulda, Simone |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5581041/ https://www.ncbi.nlm.nih.gov/pubmed/28881742 http://dx.doi.org/10.18632/oncotarget.17190 |
Ejemplares similares
-
BI-2536 and BI-6727, dual Polo-like kinase/bromodomain inhibitors, effectively reactivate latent HIV-1
por: Gohda, Jin, et al.
Publicado: (2018) -
BI6727, a polo-like kinase 1 inhibitor with promising efficacy on Burkitt lymphoma cells
por: Chen, Er, et al.
Publicado: (2020) -
Differential role of RIP1 in Smac mimetic-mediated chemosensitization of neuroblastoma cells
por: Czaplinski, Sebastian, et al.
Publicado: (2015) -
Anticancer effects of the PLK4 inhibitors CFI-400945 and centrinone in Ewing’s sarcoma cells
por: Kerschner-Morales, Sophie L., et al.
Publicado: (2020) -
Efficacy of Eribulin in Soft Tissue Sarcomas
por: Phillips, Edward, et al.
Publicado: (2022)